SEC Form D · filed August 13, 2021
Enlaza Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Shelley Chu · La Jolla, CADirectorMarcos Milla · La Jolla, CADirectorTighe Reardon · La Jolla, CAExecSanford Madigan · La Jolla, CAExecJames N. Topper · La Jolla, CADirectorSergio Duron · La Jolla, CAExec · DirectorJay Lichter · La Jolla, CADirectorBrian M. Laden · Nashville, TNDirectorChristopher Rand · Nashville, TNDirectorTyler M. Whitmore · Nashville, TNDirectorGerard M. Hayden, Jr · Nashville, TNExecMark S. Rosen · Morristown, NJDirectorRegan Bozman · San Francisco, CAExec · DirectorByron M. Smith · Nashville, TNExecMarc Chalfin · Miami Beach, FLExec · DirectorTheodore Woo · Miami Beach, FLExecMarc Chalfin · Miami Beach, FLExecEric C. Harweger · Ames, IADirectorDavid R. Phaup · Edwardsville, ILDirectorBruce E. Schneider · Venedy, ILDirectorMike D. Christensen · Edwardsville, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗